Roche launches HER2 biomarker test for breast and gastric cancer
The test “advances Roche’s commitment to personalised healthcare”.
Read More
Tag: VENTANA HER2 Dual ISH DNA Probe Cocktail
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
